DermaPhylyx

DermaPhylyx is marketing two advanced moist wound healing products: HydroMed and AlgiMed. Globally, the total market for moist wound healing dressings (composed of hydrogels, alginates, hydrocolloids, foams, and films) is estimated at $1.3 billion annually. Within this market, hydrogel and alginate dressings account for approximately $600 million per year. DermaPhylyx believes that the advanced wound management market is growing at an annual rate of 7%-9%. Over the past 40 years, the concept of moist wound care has been a significant advancement in wound treatment. Chronic wounds, such as diabetic foot ulcers, present unique treatment challenges, and a moist wound healing environment can significantly aid in addressing these challenges. Reducing the healing time of diabetic foot ulcers can lower management costs and the risk of further complications such as amputation.